145 related articles for article (PubMed ID: 38218351)
21. Immune environment in serrated lesions of the colon: intraepithelial lymphocyte density, PD-1, and PD-L1 expression correlate with serrated neoplasia pathway progression.
Acosta-Gonzalez G; Ouseph M; Lombardo K; Lu S; Glickman J; Resnick MB
Hum Pathol; 2019 Jan; 83():115-123. PubMed ID: 30172913
[TBL] [Abstract][Full Text] [Related]
22. Traditional serrated adenoma has two pathways of neoplastic progression that are distinct from the sessile serrated pathway of colorectal carcinogenesis.
Tsai JH; Liau JY; Lin YL; Lin LI; Cheng YC; Cheng ML; Jeng YM
Mod Pathol; 2014 Oct; 27(10):1375-85. PubMed ID: 24603588
[TBL] [Abstract][Full Text] [Related]
23. Usefulness of the Japan narrow-band imaging expert team classification system for the diagnosis of sessile serrated lesion with dysplasia/carcinoma.
Murakami T; Sakamoto N; Fukushima H; Shibuya T; Yao T; Nagahara A
Surg Endosc; 2021 Aug; 35(8):4528-4538. PubMed ID: 32909209
[TBL] [Abstract][Full Text] [Related]
24. Serrated Colorectal Lesions: An Up-to-Date Review from Histological Pattern to Molecular Pathogenesis.
Mezzapesa M; Losurdo G; Celiberto F; Rizzi S; d'Amati A; Piscitelli D; Ierardi E; Di Leo A
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457279
[TBL] [Abstract][Full Text] [Related]
25. BRAF V600E immunohistochemistry demonstrates that some sessile serrated lesions with adenomatous dysplasia may represent collision lesions.
Bettington M; Liu C; Gill A; Walker N; Leggett B; Whitehall V; Rosty C
Histopathology; 2019 Jul; 75(1):81-87. PubMed ID: 30825335
[TBL] [Abstract][Full Text] [Related]
26. Heterogenous loss of mismatch repair (MMR) protein expression: a challenge for immunohistochemical interpretation and microsatellite instability (MSI) evaluation.
McCarthy AJ; Capo-Chichi JM; Spence T; Grenier S; Stockley T; Kamel-Reid S; Serra S; Sabatini P; Chetty R
J Pathol Clin Res; 2019 Apr; 5(2):115-129. PubMed ID: 30387329
[TBL] [Abstract][Full Text] [Related]
27. [Comprehensive assessment of mismatch repair and microsatellite instability status in molecular classification of endometrial carcinoma].
Liu Y; Wang YX; Sun XJ; Ting X; Wu R; Liu XD; Liu CR
Zhonghua Fu Chan Ke Za Zhi; 2023 Oct; 58(10):755-765. PubMed ID: 37849256
[No Abstract] [Full Text] [Related]
28. Molecular Profiling Based on KRAS/BRAF Mutation, Methylation, and Microsatellite Statuses in Serrated Lesions.
Sugai T; Eizuka M; Fujita Y; Kawasaki K; Yamamoto E; Ishida K; Yamano H; Suzuki H; Matsumoto T
Dig Dis Sci; 2018 Oct; 63(10):2626-2638. PubMed ID: 29974407
[TBL] [Abstract][Full Text] [Related]
29. KRAS mutations in traditional serrated adenomas from Korea herald an aggressive phenotype.
Kim KM; Lee EJ; Kim YH; Chang DK; Odze RD
Am J Surg Pathol; 2010 May; 34(5):667-75. PubMed ID: 20305537
[TBL] [Abstract][Full Text] [Related]
30. Annexin A10 expression correlates with serrated pathway features in colorectal carcinoma with microsatellite instability.
Kim JH; Rhee YY; Kim KJ; Cho NY; Lee HS; Kang GH
APMIS; 2014 Dec; 122(12):1187-95. PubMed ID: 24909058
[TBL] [Abstract][Full Text] [Related]
31. DNA content analysis of colorectal serrated lesions detects an aneuploid subset of inflammatory bowel disease-associated serrated epithelial change and traditional serrated adenomas.
Choi WT; Wen KW; Rabinovitch PS; Huang D; Mattis AN; Gill RM
Histopathology; 2018 Sep; 73(3):464-472. PubMed ID: 29772067
[TBL] [Abstract][Full Text] [Related]
32. Single-cell Transcriptomics Reveals Early Molecular and Immune Alterations Underlying the Serrated Neoplasia Pathway Toward Colorectal Cancer.
Zhou YJ; Lu XF; Chen H; Wang XY; Cheng W; Zhang QW; Chen JN; Wang XY; Jin JZ; Yan FR; Chen H; Li XB
Cell Mol Gastroenterol Hepatol; 2023; 15(2):393-424. PubMed ID: 36216310
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathological and molecular characteristics of serrated lesions in Japanese elderly patients.
Nosho K; Igarashi H; Ito M; Mitsuhashi K; Kurihara H; Kanno S; Yoshii S; Mikami M; Takahashi H; Kusumi T; Hosokawa M; Sukawa Y; Adachi Y; Hasegawa T; Okita K; Hirata K; Maruyama R; Suzuki H; Imai K; Yamamoto H; Shinomura Y
Digestion; 2015; 91(1):57-63. PubMed ID: 25632919
[TBL] [Abstract][Full Text] [Related]
34. Frequent mutations of KRAS in addition to BRAF in colorectal serrated adenocarcinoma.
Stefanius K; Ylitalo L; Tuomisto A; Kuivila R; Kantola T; Sirniö P; Karttunen TJ; Mäkinen MJ
Histopathology; 2011 Apr; 58(5):679-92. PubMed ID: 21457162
[TBL] [Abstract][Full Text] [Related]
35. Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway.
Kim JH; Bae JM; Cho NY; Kang GH
Oncotarget; 2016 Mar; 7(12):14095-111. PubMed ID: 26883113
[TBL] [Abstract][Full Text] [Related]
36. Sessile serrated adenomas with low- and high-grade dysplasia and early carcinomas: an immunohistochemical study of serrated lesions "caught in the act".
Sheridan TB; Fenton H; Lewin MR; Burkart AL; Iacobuzio-Donahue CA; Frankel WL; Montgomery E
Am J Clin Pathol; 2006 Oct; 126(4):564-71. PubMed ID: 16938659
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathologic features of synchronous colorectal carcinoma: A distinct subset arising from multiple sessile serrated adenomas and associated with high levels of microsatellite instability and favorable prognosis.
Hu H; Chang DT; Nikiforova MN; Kuan SF; Pai RK
Am J Surg Pathol; 2013 Nov; 37(11):1660-70. PubMed ID: 23887157
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathologic and outcome study of sessile serrated adenomas/polyps with serrated versus intestinal dysplasia.
Cenaj O; Gibson J; Odze RD
Mod Pathol; 2018 Apr; 31(4):633-642. PubMed ID: 29271414
[TBL] [Abstract][Full Text] [Related]
39. Colorectal serrated pathway cancers and precursors.
O'Brien MJ; Zhao Q; Yang S
Histopathology; 2015 Jan; 66(1):49-65. PubMed ID: 25263173
[TBL] [Abstract][Full Text] [Related]
40. KRAS and BRAF mutations and MSI status in precursor lesions of colorectal cancer detected by colonoscopy.
Yamane LS; Scapulatempo-Neto C; Alvarenga L; Oliveira CZ; Berardinelli GN; Almodova E; Cunha TR; Fava G; Colaiacovo W; Melani A; Fregnani JH; Reis RM; Guimarães DP
Oncol Rep; 2014 Oct; 32(4):1419-26. PubMed ID: 25050586
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
